Latest Breaking News On - Epogen procrit - Page 1 : comparemela.com

Paucity of intellectual property rights information in the US biologics system a decade after passage of the Biosimilars Act

In this Policy Forum piece, Robin Feldman discusses how current legislation contributes to informational deficits around drug patents for biologic drugs in the United States.

United statesEpogen procritBlas rituxanHuman servicesDrug administrationOrange bookPurple bookBiologics price competitionInnovation actHatch waxman actBiosimilars actBiologics license applicationNew drug applicationsAbbreviated new drug applicationsPurple book continuity actContinuity act

Study highlights role of health plan type in biosimilar adoption

Study highlights role of health plan type in biosimilar adoption
independantexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from independantexpress.com Daily Mail and Mail on Sunday newspapers.

Epogen procritMaksym yemelyanovScan commercial claims

Astrazeneca PLC (NYSE:AZN), FibroGen (NYSE:FGEN) - Ahead Of AdComm AstraZeneca, FibroGen s Roxadustat Hit With Safety, Efficacy Questions

Astrazeneca PLC (NYSE:AZN), FibroGen (NYSE:FGEN) - Ahead Of AdComm AstraZeneca, FibroGen s Roxadustat Hit With Safety, Efficacy Questions
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Epogen procritFibrogen incAmgen incRenal drugs advisory committeeAstrazeneca plcமகேன் இன்க்

EU Green Light for Roxadustat in Anemia of Kidney Disease

EU Green Light for Roxadustat in Anemia of Kidney Disease
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

United statesVanderbilt universityAstellas pharma fibrogenBernhardt zeiherVolkerh haaseEpogen procritAstellas pharmaceuticalsEuropean medicines agencyEuropean commissionVanderbilt university in nashvilleDrug administrationCommittee for medicinal products human useMedicinal productsHuman useQuestions about safetyOtsuka pharmaceutical